Cardiovascular disease and the role of oral bacteria

References

• Ross R. Atherosclerosis is an inflammatory disease. Am Heart J. 1999; 138: s419–s420.
   PubMed Web of Science ®Google Scholar
• Begg S, Khor SL, Bright ML, Stanley L, O'Brien J, Harper C. Overview of the burden of disease and injury in Queensland, 2003. Queensland burden of disease and injury circular series 1, no 1. Brisbane: Queensland health. 2008.
   Google Scholar
• Heart, Stroke, and Vascular Diseases – Australian Facts 2004. Canberra: Australian Institute of Health and Welfare, National Heart Foundation of Australia, National Stroke Foundation Australia. 2004.
   Google Scholar
• Crouse JR. Progress in coronary artery disease risk factor research: what remains to be done?. Clin Chem. 1984; 30: 1125–7.
   Web of Science ®Google Scholar
• Consensus report for periodontal diseases: pathogenesis and microbial factors. Ann Periodontol. 1996; 1: 926–32.
   Google Scholar
• Papapanou PN. Periodontal diseases: epidemiology. Ann Periodontol. 1996; 1: 1–36.
   PubMedGoogle Scholar
• Mattila KJ, Valle MS, Nieminen MS, Valtonen VV, Hietaniemi KL. Dental infections and coronary atherosclerosis. Atherosclerosis. 1993; 103: 205–11.
   PubMed Web of Science ®Google Scholar
• DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993; 306: 688–91.
   PubMed Web of Science ®Google Scholar
• Valtonen VV. Role of infections in atherosclerosis. Am Heart J. 1999; 138: S431–3.
   Web of Science ®Google Scholar
• Beck JD, Elter JR, Heiss G, Couper D, Mauriello SM, Offenbacher S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2001; 21: 1816–22.
   PubMed Web of Science ®Google Scholar
• Gotsman I, Lotan C, Soskolne WA, Rassovsky S, Pugatsch T, Lapidus L, et al.. Periodontal destruction is associated with coronary artery disease and periodontal infection with acute coronary syndrome. J Periodontol. 2007; 78: 849–58.
   PubMed Web of Science ®Google Scholar
• Desvarieux M, Demmer RT, Rundek T, Boden-Albala B, Jacobs DR Jr, Sacco RL, et al.. Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation. 2005; 111: 576–82.
   PubMed Web of Science ®Google Scholar
• Joshipura KJ, Rimm CW, Douglass D. Poor oral health and coronary heart disease. J Dent Res. 1996; 75: 1631–6.
   PubMed Web of Science ®Google Scholar
• Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Periodontal disease and cardiovascular disease. JAMA. 2000; 284: 1406–10.
   PubMed Web of Science ®Google Scholar
• Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA. Pre-existing cardiovascular disease and periodontitis: a follow up study. J Dent Res. 2002; 81: 186–91.
   PubMed Web of Science ®Google Scholar
• Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J. 2007; 154: 830–7.
   PubMed Web of Science ®Google Scholar
• Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol. 2007; 78: 2289–302.
   PubMed Web of Science ®Google Scholar
• Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med. 2008; 23: 2079–86.
   PubMed Web of Science ®Google Scholar
• Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002; 105: 861–7.
   PubMed Web of Science ®Google Scholar
• Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, et al.. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2003; 23: 1405–11.
   PubMed Web of Science ®Google Scholar
• Ford PJ, Gemmell E, Timms P, Chan A, Preston FM, Seymour GJ. Anti-P. gingivalis response correlates with atherosclerosis. J Dent Res. 2007; 86: 35–40.
   PubMed Web of Science ®Google Scholar
• Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998; 25: 134–44.
   PubMed Web of Science ®Google Scholar
• Rosan B, Lamont RJ. Dental plaque formation. Microbes Infect. 2000; 2: 1599–607.
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Jenkinson HF. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev. 1998; 62: 1244–63.
   PubMed Web of Science ®Google Scholar
• Gemmell E, Seymour GJ. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontol 2000. 2004; 35: 21–41.
   PubMed Web of Science ®Google Scholar
• Cullinan MP, Hamlet SM, Westerman B, Palmer JE, Faddy MJ, Seymour GJ. Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella intermedia over a 5-year period: effect of a triclosan/copolymer dentifrice. J Clin Periodontol. 2003; 30: 532–41.
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun. 1995; 63: 3878–85.
   PubMed Web of Science ®Google Scholar
• Gemmell E, Yamazaki K, Seymour GJ. Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med. 2002; 13: 17–34.
   PubMedGoogle Scholar
• Gemmell E, Carter CL, Hart DN, Drysdale KE, Seymour GJ. Antigen-presenting cells in human periodontal disease tissues. Oral Microbiol Immunol. 2002; 17: 388–93.
   Google Scholar
• Gemmell E, Sernia C, Grieco DA, Bird PS, Allen CJ, Seymour GJ. Genetic variation in the recognition of Porphyromonas gingivalis antigens in mice. Oral Microbiol Immunol. 2001; 16: 129–35.
   Google Scholar
• Gemmell E, Bird PS, Carter CL, Drysdale KE, Seymour GJ. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model. Clin Exp Immunol. 2002; 128: 238–44.
   Web of Science ®Google Scholar
• Milward MR, Chapple IL, Wright HJ, Millard JL, Matthews JB, Cooper PR. Differential activation of NF-kappaB and gene expression in oral epithelial cells by periodontal pathogens. Clin Exp Immunol. 2007; 148: 307–24.
   PubMed Web of Science ®Google Scholar
• Bodet C, Chandad F, Grenier D. Inflammatory responses of a macrophage/epithelial cell co-culture model to mono and mixed infections with Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia. Microbes Infect. 2006; 8: 27–35.
   PubMed Web of Science ®Google Scholar
• Ji S, Kim Y, Min BM, Han SH, Choi Y. Innate immune responses of gingival epithelial cells to nonperiodontopathic and periodontopathic bacteria. J Periodontal Res. 2007; 42: 503–10.
   Web of Science ®Google Scholar
• Grenier D. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis. Infect Immun. 1992; 60: 482–90.
   Web of Science ®Google Scholar
• Yao ES, Lamont RJ, Leu SP, Weinberg A. Interbacterial binding among strains of pathogenic and commensal oral bacterial species. Oral Microbiol Immunol. 1996; 11: 35–41.
   Google Scholar
• Saito A, Inagaki S, Kimizuka R, Okuda K, Hosaka Y, Nakagawa T, et al.. Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis. FEMS Immunol Med Microbiol. 2008; 54: 349–55.
   PubMedGoogle Scholar
• Metzger Z, Blasbalg J, Dotan M, Weiss EI. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum. J Endod. 2009; 35: 82–5.
   PubMed Web of Science ®Google Scholar
• Kesavalu L, Holt SC, Ebersole JL. Virulence of a polymicrobic complex, Treponema denticola and Porphyromonas gingivalis, in a murine model. Oral Microbiol Immunol. 1998; 13: 373–7.
   Google Scholar
• Yoneda M, Hirofuji T, Anan H, Matsumoto A, Hamachi T, Nakayama K, et al.. Mixed infection of Porphyromonas gingivalis and Bacteroides forsythus in a murine abscess model: involvement of gingipains in a synergistic effect. J Periodontal Res. 2001; 36: 237–43.
   Web of Science ®Google Scholar
• Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol. 2005; 17: 1–14.
   PubMed Web of Science ®Google Scholar
• Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, Van der Meer JW. Does the shape of lipid A determine the interaction of LPS with toll-like receptors?. Trends Immunol. 2002; 23: 135–9.
   PubMed Web of Science ®Google Scholar
• Hayashi J, Masaka T, Ishikawa I. Increased levels of soluble CD14 in sera of periodontitis patients. Infect Immun. 1999; 67: 417–20.
   Web of Science ®Google Scholar
• Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007; 27: 1433–9.
   Web of Science ®Google Scholar
• Bascones-Martinez A, Munoz-Corcuera M, Noronha S, Mota P, Bascones-Ilundain C, Campo-Trapero J. Host defence mechanisms against bacterial aggression in periodontal disease: basic mechanisms. Med Oral Patol Oral Cir Bucal. 2009; 14: e680–5.
   PubMed Web of Science ®Google Scholar
• Dixon DR, Bainbridge BW, Darveau RP. Modulation of the innate immune response within the periodontium. Periodontol 2000. 2004; 35: 53–74.
   PubMed Web of Science ®Google Scholar
• Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann NY Acad Sci. 2007; 1098: 230–51.
   PubMed Web of Science ®Google Scholar
• Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol. 1992; 63: 338–55.
   PubMed Web of Science ®Google Scholar
• Ebersole JL. Humoral immune responses in gingival crevice fluid: local and systemic implications. Periodontol 2000. 2003; 31: 135–66.
   PubMed Web of Science ®Google Scholar
• Schifferle RE, Wilson ME, Levine MJ, Genco RJ. Activation of serum complement by polysaccharide-containing antigens of Porphyromonas gingivalis. J Periodontal Res. 1993; 28: 248–54.
   Web of Science ®Google Scholar
• Imamura T. The role of gingipains in the pathogenesis of periodontal disease. J Periodontol. 2003; 74: 111–8.
   PubMed Web of Science ®Google Scholar
• Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci. 2003; 4: 397–407.
   PubMed Web of Science ®Google Scholar
• Abe N, Kadowaki T, Okamoto K, Nakayama K, Ohishi M, Yamamoto K. Biochemical and functional properties of lysine-specific cysteine proteinase (Lys-gingipain) as a virulence factor of Porphyromonas gingivalis in periodontal disease. J Biochem. 1998; 123: 305–12.
   Web of Science ®Google Scholar
• Lantz MS, Allen RD, Duck LW, Blume JL, Switalski LM, Hook M. Identification of Porphyromonas gingivalis components that mediate its interactions with fibronectin. J Bacteriol. 1991; 173: 4263–70.
   Web of Science ®Google Scholar
• Pike RN, Potempa J, McGraw W, Coetzer TH, Travis J. Characterization of the binding activities of proteinase-adhesion complexes from Porphyromonas gingivalis. J Bacteriol. 1996; 178: 2876–82.
   PubMed Web of Science ®Google Scholar
• Nakayama K, Kadowaki T, Okamoto K, Yamamoto K. Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence. J Biol Chem. 1995; 270: 23619–26.
   PubMed Web of Science ®Google Scholar
• Calkins CC, Platt K, Potempa J, Travis J. Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem. 1998; 273: 6611–4.
   Web of Science ®Google Scholar
• Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J. Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun. 1999; 261: 598–602.
   Web of Science ®Google Scholar
• Kadowaki T, Nakayama K, Yoshimura F, Okamoto K, Abe N, Yamamoto K. Arg-gingipain acts as a major processing enzyme for various cell surface proteins in Porphyromonas gingivalis. J Biol Chem. 1998; 273: 29072–6.
   Web of Science ®Google Scholar
• Oleksy A, Banbula A, Bugno M, Travis J, Potempa J. Proteolysis of interleukin-6 receptor (IL-6R) by Porphyromonas gingivalis cysteine proteinases (gingipains) inhibits interleukin-6-mediated cell activation. Microb Pathog. 2002; 32: 173–81.
   Web of Science ®Google Scholar
• Imamura T, Pike RN, Potempa J, Travis J. Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway. J Clin Invest. 1994; 94: 361–7.
   PubMed Web of Science ®Google Scholar
• Imamura T, Potempa J, Tanase S, Travis J. Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem. 1997; 272: 16062–7.
   PubMed Web of Science ®Google Scholar
• Wingrove JA, DiScipio RG, Chen Z, Potempa J, Travis J, Hugli TE. Activation of complement components C3 and C5 by a cysteine proteinase (gingipain-1) from Porphyromonas (bacteroides) gingivalis. J Biol Chem. 1992; 267: 18902–7.
   PubMed Web of Science ®Google Scholar
• Ransjo M, Marklund M, Persson M, Lerner UH. Synergistic interactions of bradykinin, thrombin, interleukin 1 and tumor necrosis factor on prostanoid biosynthesis in human periodontal-ligament cells. Arch Oral Biol. 1998; 43: 253–60.
   Web of Science ®Google Scholar
• Rahman S, Bunning RA, Dobson PR, Evans DB, Chapman K, Jones TH, et al.. Bradykinin stimulates the production of prostaglandin E2 and interleukin-6 in human osteoblast-like cells. Biochim Biophys Acta. 1992; 1135: 97–102.
   Google Scholar
• Sugawara S, Nemoto E, Tada H, Miyake K, Imamura T, Takada H. Proteolysis of human monocyte CD14 by cysteine proteinases (gingipains) from Porphyromonas gingivalis leading to lipopolysaccharide hyporesponsiveness. J Immunol. 2000; 165: 411–8.
   PubMed Web of Science ®Google Scholar
• Duncan L, Yoshioka M, Chandad F, Grenier D. Loss of lipopolysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog. 2004; 36: 319–25.
   PubMed Web of Science ®Google Scholar
• Tokuda M, Duncan M, Cho MI, Kuramitsu HK. Role of Porphyromonas gingivalis protease activity in colonization of oral surfaces. Infect Immun. 1996; 64: 4067–73.
   Web of Science ®Google Scholar
• Tokuda M, Karunakaran T, Duncan M, Hamada N, Kuramitsu H. Role of Arg-gingipain A in virulence of Porphyromonas gingivalis. Infect Immun. 1998; 66: 1159–66.
   PubMed Web of Science ®Google Scholar
• Kuramitsu H, Tokuda M, Yoneda M, Duncan M, Cho MI. Multiple colonization defects in a cysteine protease mutant of Porphyromonas gingivalis. J Periodontal Res. 1997; 32: 140–2.
   Web of Science ®Google Scholar
• Yoneda M, Hirofuji T, Motooka N, Anan H, Hamachi T, Miura M, et al.. Antibody responses to Porphyromonas gingivalis infection in a murine abscess model – involvement of gingipains and responses to re-infection. J Periodontal Res. 2003; 38: 551–6.
   Web of Science ®Google Scholar
• Kuramitsu HK. Proteases of Porphyromonas gingivalis: what don't they do?. Oral Microbiol Immunol. 1998; 13: 263–70.
   Google Scholar
• Shi Y, Ratnayake DB, Okamoto K, Abe N, Yamamoto K, Nakayama K. Genetic analyses of proteolysis, hemoglobin binding, and hemagglutination of Porphyromonas gingivalis. Construction of mutants with a combination of rgpA, rgpB, kgp, and hagA. J Biol Chem. 1999; 274: 17955–60.
   PubMed Web of Science ®Google Scholar
• McKee AS, McDermid AS, Baskerville A, Dowsett AB, Ellwood DC, Marsh PD. Effect of hemin on the physiology and virulence of Bacteroides gingivalis W50. Infect Immun. 1986; 52: 349–55.
   PubMed Web of Science ®Google Scholar
• Genco CA, Odusanya BM, Potempa J, Mikolajczyk-Pawlinska J, Travis J. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice. Infect Immun. 1998; 66: 4108–14.
   PubMed Web of Science ®Google Scholar
• O'Brien-Simpson NM, Paolini RA, Reynolds EC. RgpA-Kgp peptide-based immunogens provide protection against Porphyromonas gingivalis challenge in a murine lesion model. Infect Immun. 2000; 68: 4055–63.
   PubMed Web of Science ®Google Scholar
• Beveridge TJ, Makin SA, Kadurugamuwa JL, Li Z. Interactions between biofilms and the environment. FEMS Microbiol Rev. 1997; 20: 291–303.
   PubMed Web of Science ®Google Scholar
• Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci. 2007; 12: 3965–74.
   PubMed Web of Science ®Google Scholar
• Isogai H, Isogai E, Yoshimura F, Suzuki T, Kagota W, Takano K. Specific inhibition of adherence of an oral strain of Bacteroides gingivalis 381 to epithelial cells by monoclonal antibodies against the bacterial fimbriae. Arch Oral Biol. 1988; 33: 479–85.
   Web of Science ®Google Scholar
• Weinberg A, Belton CM, Park Y, Lamont RJ. Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun. 1997; 65: 313–6.
   PubMed Web of Science ®Google Scholar
• Njoroge T, Genco RJ, Sojar HT, Hamada N, Genco CA. A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun. 1997; 65: 1980–4.
   PubMed Web of Science ®Google Scholar
• Amano A, Nakagawa I, Okahashi N, Hamada N. Variations of Porphyromonas gingivalis fimbriae in relation to microbial pathogenesis. J Periodontal Res. 2004; 39: 136–42.
   PubMed Web of Science ®Google Scholar
• Lamont RJ, Yilmaz O. In or out: the invasiveness of oral bacteria. Periodontol 2000. 2002; 30: 61–9.
   PubMed Web of Science ®Google Scholar
• Hamada S, Fujiwara T, Morishima S, Takahashi I, Nakagawa I, Kimura S, et al.. Molecular and immunological characterization of the fimbriae of Porphyromonas gingivalis. Microbiol Immunol. 1994; 38: 921–30.
   Web of Science ®Google Scholar
• Nakagawa I, Amano A, Kimura RK, Nakamura T, Kawabata S, Hamada S. Distribution and molecular characterization of Porphyromonas gingivalis carrying a new type of fimA gene. J Clin Microbiol. 2000; 38: 1909–14.
   PubMed Web of Science ®Google Scholar
• Nakagawa I, Amano A, Ohara-Nemoto Y, Endoh N, Morisaki I, Kimura S, et al.. Identification of a new variant of fimA gene of Porphyromonas gingivalis and its distribution in adults and disabled populations with periodontitis. J Periodontal Res. 2002; 37: 425–32.
   PubMed Web of Science ®Google Scholar
• Bodet C, Chandad F, Grenier D. Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model. Clin Exp Immunol. 2006; 143: 50–7.
   Web of Science ®Google Scholar
• Perez-Chaparro PJ, Lafaurie GI, Gracieux P, Meuric V, Tamanai-Shacoori Z, Castellanos JE, et al.. Distribution of Porphyromonas gingivalis fimA genotypes in isolates from subgingival plaque and blood sample during bacteremia. Biomedica. 2009; 29: 298–306.
   Web of Science ®Google Scholar
• Amano A, Kuboniwa M, Nakagawa I, Akiyama S, Morisaki I, Hamada S. Prevalence of specific genotypes of Porphyromonas gingivalis fimA and periodontal health status. J Dent Res. 2000; 79: 1664–8.
   PubMed Web of Science ®Google Scholar
• Eick S, Rodel J, Einax JW, Pfister W. Interaction of Porphyromonas gingivalis with KB cells: comparison of different clinical isolates. Oral Microbiol Immunol. 2002; 17: 201–8.
   Google Scholar
• Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S. Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol. 1999; 37: 1426–30.
   PubMed Web of Science ®Google Scholar
• Nakano K, Kuboniwa M, Nakagawa I, Yamamura T, Nomura R, Okahashi N, et al.. Comparison of inflammatory changes caused by Porphyromonas gingivalis with distinct fimA genotypes in a mouse abscess model. Oral Microbiol Immunol. 2004; 19: 205–9.
   PubMedGoogle Scholar
• Narayanan SK, Nagaraja TG, Chengappa MM, Stewart GC. Leukotoxins of Gram-negative bacteria. Vet Microbiol. 2002; 84: 337–56.
   PubMed Web of Science ®Google Scholar
• Johansson A, Claesson R, Hanstrom L, Sandstrom G, Kalfas S. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res. 2000; 35: 85–92.
   PubMed Web of Science ®Google Scholar
• Mangan DF, Taichman NS, Lally ET, Wahl SM. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun. 1991; 59: 3267–72.
   Web of Science ®Google Scholar
• Pucar A, Milasin J, Lekovic V, Vukadinovic M, Ristic M, Putnik S, et al.. Correlation between atherosclerosis and periodontal putative pathogenic bacterial infections in coronary and internal mammary arteries. J Periodontol. 2007; 78: 677–82.
   PubMed Web of Science ®Google Scholar
• Campbell JH, Campbell GR. The cell biology of atherosclerosis – new developments. Aust NZ J Med. 1997; 27: 497–500.
   PubMedGoogle Scholar
• Libby P. Inflammation in atherosclerosis. Nature. 2002; 420: 868–74.
   PubMed Web of Science ®Google Scholar
• Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006; 1: 297–329.
   PubMed Web of Science ®Google Scholar
• Jawien J. New insights into immunological aspects of atherosclerosis. Pol Arch Med Wewn. 2008; 118: 127–31.
   PubMedGoogle Scholar
• Nanci A, Bosshardt DD. Structure of periodontal tissues in health and disease. Periodontol 2000. 2006; 40: 11–28.
   PubMed Web of Science ®Google Scholar
• Parahitiyawa NB, Jin LJ, Leung WK, Yam WC, Samaranayake LP. Microbiology of odontogenic bacteremia: beyond endocarditis. Clin Microbiol Rev. 2009; 22: 46–64.
   PubMed Web of Science ®Google Scholar
• Kinane DF, Riggio MP, Walker KF, MacKenzie D, Shearer B. Bacteraemia following periodontal procedures. J Clin Periodontol. 2005; 32: 708–13.
   PubMed Web of Science ®Google Scholar
• Forner L, Larsen T, Kilian M, Holmstrup P. Incidence of bacteraemia after chewing, tooth brushing and scaling in individuals with periodontal inflammation. J Clin Periodontol. 2006; 33: 401–7.
   PubMed Web of Science ®Google Scholar
• Crasta K, Daly CG, Mitchell D, Curtis B, Stewart D, Heitz-Mayfield LJA. Bacteraemia due to dental flossing. J Clin Periodontol. 2009; 36: 323–32.
   Web of Science ®Google Scholar
• Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000; 71: 1554–60.
   PubMed Web of Science ®Google Scholar
• Kozarov VI, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porpyromonas gingivalis. Arterioscler Thromb Vasc Biol. 2005; 25: e17–8.
   PubMed Web of Science ®Google Scholar
• Elkaim R, Dahan M, Kocgozlu L, Werner S, Kanter D, Kretz JG, et al.. The prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques, and healthy blood vessels: a preliminary study. J Periodont Res. 2008; 43: 224–31.
   Web of Science ®Google Scholar
• Ford PJ, Gemmell E, Hamlet SM, Hasan A, Walker PJ, West MJ, et al.. Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol. 2005; 20: 296–302.
   PubMedGoogle Scholar
• Ford PJ, Gemmell E, Chan A, Carter CL, Walker PJ, Bird PS, et al.. Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol. 2006; 21: 206–11.
   PubMedGoogle Scholar
• Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, et al.. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol. 2009; 24: 64–8.
   PubMedGoogle Scholar
• Gaetti-Jardim E Jr, Marcelino SL, Feitosa AC, Romito GA, Avila-Campos MJ. Quantitative detection of periodontopathic bacteria in atherosclerotic plaques from coronary arteries. J Med Microbiol. 2009; 58: 1568–75.
   Web of Science ®Google Scholar
• Giacona MB, Papapanou PN, Lamster IB, Rong LL, D'Agati VD, Schmidt AM. Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol Lett. 2004; 241: 95–101.
   Web of Science ®Google Scholar
• Deshpande RG, Khan MB, Genco CA. Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun. 1998; 66: 5337–43.
   PubMed Web of Science ®Google Scholar
• Dorn BR, Dunn WA Jr, Progulske-Fox A. Invasion of human coronary artery cells by periodontal pathogens. Infect Immun. 1999; 67: 5792–8.
   PubMed Web of Science ®Google Scholar
• Abranches J, Zeng L, Belanger M, Rodrigues PH, Simpson-Haidaris PJ, Akin D, et al.. Invasion of human coronary artery endothelial cells by Streptococcus mutans OMZ175. Oral Microbiol Immunol. 2009; 24: 141–5.
   Google Scholar
• Dorn BR, Dunn WA Jr, Progulske-Fox A. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect Immun. 2001; 69: 5698–708.
   PubMed Web of Science ®Google Scholar
• Roth GA, Moser B, Huang SJ, Brandt JS, Huang Y, Papapanou PN, et al.. Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost. 2006; 4: 2256–61.
   PubMed Web of Science ®Google Scholar
• Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN, et al.. Infection with periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis. 2007; 190: 271–81.
   PubMed Web of Science ®Google Scholar
• Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol Lett. 2007; 272: 106–13.
   Web of Science ®Google Scholar
• Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol. 2004; 25: 489–95.
   PubMed Web of Science ®Google Scholar
• Kerrigan SW, Jakubovics NS, Keane C, Maguire P, Wynne K, Jenkinson HF, et al.. Role of Streptococcus gordonii surface proteins SspA/SspB and Hsa in platelet function. Infect Immun. 2007; 75: 5740–47.
   PubMed Web of Science ®Google Scholar
• Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol. 2006; 4: 445–57.
   PubMed Web of Science ®Google Scholar
• Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci. 2010; 67: 513–23.
   PubMed Web of Science ®Google Scholar
• Erickson PR, Herzberg MC. The Streptococcus sanguis platelet aggregation-associated protein. J Biol Chem. 1993; 268: 1646–9.
   PubMed Web of Science ®Google Scholar
• Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Douglas CWI. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol. 2005; 129: 101–9.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Ruhl S, Yoon JW, Sandberg AL, Cisar JO. Adhesion of biridans group streptococci to sialic acid-, galactose-, and N-acetylgalactosamine-containing receptors. Oral Microbiol Immunol. 2002; 17: 257–62.
   Google Scholar
• Taniguchi N, Nakano K, Nomura R, Naka S, Kojima A, Matsumoto M, et al.. Defect of glucosyltransferases reduces platelet aggregation activity of Streptococcus mutans: analysis of clinical strains isolated from oral cavities. Arch Oral Biol. 2010; 55: 410–6.
   Web of Science ®Google Scholar
• Sharma A, Novak EK, Sojar HT, Swank RT, Kuramitsu HK, Genco RJ. Porphyromonas gingivalis platelet aggregation activity: outer membrane vesicles are potent activators of murine platelets. Oral Microbiol Immunol. 2000; 15: 393–6.
   PubMedGoogle Scholar
• Herzberg MC, MacFarlane GD, Liu P, Erickson PR. In: Molecular pathogenesis of periodontal diseases. WashingtonDC: ASM Press. 1994.
   Google Scholar
• Holt SC, Bramanti TE. Factors in virulence expression and their role in periodontal disease pathogenesis. Crit Rev Oral Biol Med. 1991; 2: 177–281.
   PubMedGoogle Scholar
• Naito M, Sakai E, Shi Y, Ideguchi H, Shoji M, Ohara N, et al.. Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesion but not Rgp proteinase. Mol Microbiol. 2006; 59: 152–67.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342: 836–43.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000; 101: 2149–53.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000; 101: 1767–72.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347: 1557–65.
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE, Gotto AM Jr, et al.. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 1997; 96: 4219–25.
   PubMed Web of Science ®Google Scholar
• Stoll LL, Denning GM, Weintraub NL. Potential role of edotoxin as a proinflammatory mediator in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24: 2227–36.
   PubMed Web of Science ®Google Scholar
• Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res. 2000; 79: 49–57.
   PubMed Web of Science ®Google Scholar
• Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol. 2003; 23: 1245–9.
   PubMed Web of Science ®Google Scholar
• Ebersole JE, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol. 1997; 107: 347–52.
   PubMed Web of Science ®Google Scholar
• Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol. 2001; 72: 1221–7.
   PubMed Web of Science ®Google Scholar
• Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol. 2000; 71: 1528–34.
   PubMed Web of Science ®Google Scholar
• Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H, et al.. Periodontitis-associated up-regulation of systemic inflammatory mediator level may increase the risk of coronary heart disease. J Periodontal Res. 2010; 45: 116–22.
   PubMed Web of Science ®Google Scholar
• Nibali L, D'Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol. 2007; 34: 931–7.
   PubMed Web of Science ®Google Scholar
• Ide M, Jagadev D, Coward PY, Crook M, Barclay GR, Wilson RF. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol. 2004; 75: 420–8.
   PubMed Web of Science ®Google Scholar
• D'Auito F, Parkar M, Tonetti MS. Acute effects of periodontal therapy on bio-markers of vascular health. J Clin Periodontol. 2007; 34: 124–9.
   Web of Science ®Google Scholar
• Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M, et al.. Treatment of periodontitis and endothelial function. N Engl J Med. 2007; 356: 911–20.
   PubMed Web of Science ®Google Scholar
• Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N, et al.. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J. 2006; 151: e1–e47.
   Web of Science ®Google Scholar
• Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T, Yoshie H, et al.. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res. 2005; 40: 53–8.
   PubMed Web of Science ®Google Scholar
• Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Pussinen PJ, et al.. Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis. 2009; 206: 518–22.
   PubMed Web of Science ®Google Scholar
• D'Auito F, Parkar M, Nibali L, Suvan J, Lessem J, Tonetti M. Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomised controlled clinical trial. Am Heart J. 2006; 151: 977–84.
   Web of Science ®Google Scholar
• Vidal F, Figueredo CM, Cordovil I, Fischer RG. Periodontal therapy reduces plasma levels of interleukin-6, C-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol. 2009; 80: 786–91.
   PubMed Web of Science ®Google Scholar
• Hussain Bokhari SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M. Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. J Periodontol. 2009; 80: 1574–80.
   Web of Science ®Google Scholar
• Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R, Kebschull M, et al.. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol. 2009; 36: 287–94.
   PubMed Web of Science ®Google Scholar
• D'Aiuto F, Parkar M, Brett PM, Ready D, Tonetti MS. Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. Cytokine. 2004; 28: 29–34.
   PubMed Web of Science ®Google Scholar
• Means RT. Hepcidin and cytokines in anaemia. Hematology. 2004; 9: 357–62.
   PubMedGoogle Scholar
• Hutter JW, van der Velden U, Varoufaki A, Huffels RA, Hoek FJ, Loos BG. Lower numbers of erythrocytes and lower levels of hemoglobin in periodontitis patients compared to control subjects. J Clin Periodontol. 2001; 28: 930–6.
   PubMed Web of Science ®Google Scholar
• Pradeep AR, Sharma A, Arjun Raju P.. Anemia of chronic disease and chronic periodontitis: does periodontal therapy have effect on anemic status. J Periodontol. 2010: aheadofprint.
   Google Scholar
• Taylor B, Tofler G, Morel-Kopp MC, Carey H, Carter T, Elliott M, et al.. The effect of initial treatment of periodontitis on systemic markers of inflammation and cardiovascular risk: a randomized controlled trial. Eur J Oral Sci. 2010; 118: 350–6.
   PubMed Web of Science ®Google Scholar
• Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008; 35: 277–90.
   PubMed Web of Science ®Google Scholar
• Wick G, Perschinka H, Xu Q. Autoimmunity and atherosclerosis. Am Heart J. 1999; 138: s444–9.
   PubMed Web of Science ®Google Scholar
• Polla BS. A role for heat shock proteins in inflammation?. Immunol Today. 1988; 9: 134–7.
   PubMedGoogle Scholar
• Fink AL. Chaperone-mediated protein folding. Physiol Rev. 1999; 79: 425–9.
   PubMed Web of Science ®Google Scholar
• Kauffman S. Heat shock proteins and the immune response. Immunol Today. 1990; 11: 129–36.
   PubMedGoogle Scholar
• Perschinka H, Mayr M, Millonig G, Mayerl C, van der Zee R, Morrison SG, et al.. Cross-reactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol. 2003; 23: 1060–5.
   PubMed Web of Science ®Google Scholar
• Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J, et al.. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease. Circulation. 2001; 103: 1071–5.
   PubMed Web of Science ®Google Scholar
• Metzler B, Schett G, Kleindienst R, van der Zee R, Ottenhoff T, Hajeer A, et al.. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol. 1997; 17: 536–41.
   PubMed Web of Science ®Google Scholar
• Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, et al.. Endothelial cytotoxicity mediated by serum antibodies to heat-shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat-shock proteins as a possible link between infection and atherosclerosis. Circulation. 1999; 99: 1560–6.
   PubMed Web of Science ®Google Scholar
• Ellins E, Shamaei-Tousi A, Steptoe A, Donald A, O'Meagher S, Halcox J, et al.. The relationship between carotid stiffness and circulation levels of heat shock protein 60 in middle-aged men and women. J Hypertens. 2008; 26: 2389–92.
   PubMed Web of Science ®Google Scholar
• Pockley AG, Wu R, Lemne C, Kiessling R, de Faire U, Frostegard J. Circulating heat shock protein 60 is associated with early cardiovascular disease. Hypertension. 2000; 36: 303–7.
   PubMed Web of Science ®Google Scholar
• Xu Q, Wick G. The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today. 1996; 2: 372–9.
   Google Scholar
• Welch WJ. Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells. Phil Trans R Soc Lond B Biol Sci. 1993; 339: 327–33.
   PubMed Web of Science ®Google Scholar
• Goulhen F, Grenier D, Mayrand D. Oral microbial heat-shock proteins and their potential contributions to infections. Crit Rev Oral Biol Med. 2003; 14: 399–412.
   Google Scholar
• Maeda H, Miyamoto M, Hongyo H, Nagai A, Kurihara H, Muryama Y. Heat shock protein 60 (GroEL) from Porphyromonas gingivalis: molecular cloning and sequence analysis of its gene and purification of the recombinant protein. FEMS Microbiol Lett. 1994; 119: 129–35.
   PubMed Web of Science ®Google Scholar
• Tabeta K, Yamazaki K, Hotokezaka H, Yoshie H, Hara K. Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients. Clin Exp Immunol. 2000; 120: 285–93.
   PubMed Web of Science ®Google Scholar
• Yamazaki K, Ohsawa Y, Tabeta K, Ito H, Ueki K, Oda T, et al.. Accumulation of human heat shock protein 60-reactive T cells in the gingival tissues of periodontitis patients. Infect Immun. 2002; 70: 2492–501.
   Web of Science ®Google Scholar
• Ford P, Gemmell E, Walker P, West M, Cullinan M, Seymour G. Characterisation of heat shock protein-specific T cells in atherosclerosis. Clin Diagn Lab Immunol. 2005; 12: 259–67.
   PubMedGoogle Scholar
• Yamazaki K, Ueki-Maruayama K, Honda T, Nakajima T, Seymour GJ. Effect of periodontal treatment on the serum antibody levels to heat shock proteins. Clin Exp Immunol. 2004; 135: 478–82.
   Web of Science ®Google Scholar
• George J, Shoenfeld Y, Afek A, Gilburd B, Keren P, Shaish A, et al.. Enhanced fatty streak formation in C57BL/6 mice by immunisation with heat shock protein-65. Arterioscler Thromb Vasc Biol. 1999; 19: 505–10.
   PubMed Web of Science ®Google Scholar
• Foteinos G, Afzal AR, Mandal K, Jahangiri M, Xu Q. Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage. Circulation. 2005; 112: 1206–13.
   PubMed Web of Science ®Google Scholar
• van Puijvelde GHM, van Es T, van Wanrooij EJA, Habets KLL, deVos P, van der Zee R, et al.. Induction of oral tolerance to HSP60 or and HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler Thromb Vasc Biol. 2007; 27: 2677–83.
   PubMed Web of Science ®Google Scholar
• Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al.. The American Journal of Cardiology and Journal of Periodontology editors’ consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009; 80: 1021–32.
   PubMed Web of Science ®Google Scholar